[Treatment of progressive scleroderma using carnitine].
D000328:Adult; D001775:Blood Circulation / Q000187:drug effects; D002331:Carnitine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003911:Dextrans / Q000627:therapeutic use; D003875:Drug Eruptions / Q000139:chemically induced; D004341:Drug Evaluation; D004361:Drug Tolerance; D004548:Elasticity; D005260:Female; D005334:Fever / Q000139:chemically induced; D006801:Humans; D008875:Middle Aged; D011374:Progesterone / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000188:drug therapy*
D003911:Dextrans; D011374:Progesterone; D002331:Carnitine
Die Behandlung der progressiven Sklerodermie mit Carnitin